美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Corgi All World 2x Daily ETF

24.41

+0.02890.12%

成交量：24

成交额：595

市值：61.03万

市盈率：- -

高：24.41

开：24.38

低：24.41

收：24.38

52周最高：25.58

52周最低：20.48

股本：2.50万

流通股本：2.50万

量比：0.23

换手率：0.10%

股息：- -

股息率：- -

净资产收益率：--

总资产收益率：--

市净率：--

市盈率(LYR):- -

数据加载中...

总览公司新闻资讯公告

再次突破半年线！全市场规模最大医疗ETF（512170）摸高1.54%，AI医疗、CXO携手拉涨！港股通医疗同步走强

【券商聚焦】中信建投：CXO个股订单加速兑现，行业内需企稳回升

医药外包概念全线扬升昭衍新药(06127)涨7.93% 机构指CXO景气进入中报业绩兑现期

中信建投：2026年国内CRO/CDMO行业的新签订单及业绩会加速增长，带动CXO产业链进入新一轮发展阶段

中信建投：CXO板块Beta稳中向好个股订单加速兑现

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hans/stock/WX/news?page=4"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"WX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"WX\",,,,,undefined,":{"symbol":"WX","market":"US","secType":"STK","nameCN":"Corgi All World 2x Daily ETF","latestPrice":24.4107,"timestamp":1791921600000,"preClose":24.3818,"halted":0,"volume":24,"delay":0,"changeRate":0.0011853103544447149,"floatShares":25000,"shares":25000,"eps":0,"marketStatus":"已收盘","change":0.0289,"latestTime":"10-13 16:00:00 EDT","open":24.3818,"high":24.4107,"low":24.4107,"amount":595,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1791964800000},"marketStatusCode":5,"adr":0,"exchange":"CBOE","adjPreClose":24.3818,"nav":24.37,"aum":609250,"bidAskSpread":0,"volumeRatio":0.225988},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"WX\",,,,,undefined,":{"symbol":"WX","floatShares":25000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.225988,"shares":25000,"dividePrice":0,"high":24.4107,"amplitude":0,"preClose":24.3818,"low":24.4107,"week52Low":20.48,"pbRate":"--","week52High":25.58,"institutionHeld":0,"latestPrice":24.4107,"eps":0,"divideRate":0,"volume":24,"delay":0,"ttmEps":0,"open":24.3818,"prevYearClose":24.72,"prevWeekClose":24.4952,"prevMonthClose":23.9994,"prevQuarterClose":23.9994,"fiveDayClose":24.8004,"twentyDayClose":24.0016,"sixtyDayClose":23.5672},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/WX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"WX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"WX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"WX\",pageSize:20,pageCount:4,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2655933513","title":"再次突破半年线！全市场规模最大医疗ETF（512170）摸高1.54%，AI医疗、CXO携手拉涨！港股通医疗同步走强","url":"https://stock-news.laohu8.com/highlight/detail?id=2655933513","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655933513?lang=zh_cn&edition=fundamental","pubTime":"2026-07-31 10:52","pubTimestamp":1785466320,"startTime":"0","endTime":"0","summary":"7月31日，A股医疗板块低开高走，全市场规模最大医疗ETF华宝上探1.54%，连续第3日盘中突破半年线！成份股涨跌互现，AI医疗概念领涨，迪安诊断、九安医疗、奕瑞科技齐涨超7%。医疗器械回调，迈瑞医疗、联影医疗跌逾1%。港股通医疗ETF华宝：重仓创新药产业链，48%CXO+20%创新药，兼顾AI医疗、医疗器械等领域稀缺龙头，底层资产是港股，高弹性，T+0。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-07-31/doc-inikshrh9344635.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["CXO","AIPO","CHAT","159891","FLHK","512170","QTOC","159828","AGIX","VTHR","ARTY","WX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655724380","title":"【券商聚焦】中信建投：CXO个股订单加速兑现，行业内需企稳回升","url":"https://stock-news.laohu8.com/highlight/detail?id=2655724380","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655724380?lang=zh_cn&edition=fundamental","pubTime":"2026-07-31 09:12","pubTimestamp":1785460332,"startTime":"0","endTime":"0","summary":"26年至今国内创新药行业的长期结构性机会持续兑现，国内投融资持续改善，新药物形式赛道持续火热并进一步放量，该机构认为26年国内CRO/CDMO行业的新签订单及业绩会加速增长，带动CXO产业链进入新一轮发展阶段。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250109/M2QyMTYxN2UxNmI4NDk2OTg5NThlNDVhNTUzNjZhZTcxMjcxMzE0NDc4MDA=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/M2QyMTYxN2UxNmI4NDk2OTg5NThlNDVhNTUzNjZhZTcxMjcxMzE0NDc4MDA=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1987181","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999004311.SGD","LU0348783233.USD","09688","601066","BK1141","LU0348825331.USD","LU1969619763.USD","LU2476274308.USD","LU2778985437.USD","LU1770034418.SGD","LU0634319403.HKD","09926","01789","03933","LU0640798160.USD","KURE","02228","LU2328871848.SGD","LU0417516571.SGD","KCE","BK1191","06160","BK1515","WX","LU0348784397.USD","LU1794554557.SGD","BK0276","BK1617","BK1161","LU1961090484.USD","02268","BK1500","01530","IE00B3M56506.USD","06821","BK1585","LU1251922891.USD","LU1303224171.USD","BK1197","IE00B5MMRT66.SGD","LU2488822045.USD","LU0540923850.HKD","02367","LU0348827113.USD","CXO","01099","LU2476274720.SGD","LU0348767384.USD","LU0348735423.USD","02196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654095486","title":"医药外包概念全线扬升 昭衍新药(06127)涨7.93% 机构指CXO景气进入中报业绩兑现期","url":"https://stock-news.laohu8.com/highlight/detail?id=2654095486","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654095486?lang=zh_cn&edition=fundamental","pubTime":"2026-07-27 10:17","pubTimestamp":1785118673,"startTime":"0","endTime":"0","summary":"消息面上，开源证券新近研究指出，7月以来，康龙化成、昭衍新药、美迪西和药康生物先后发布2026年H1业绩预增公告，从早研到临床前研究，CXO景气周期已逐步进入利润表兑现期。根据医药魔方，2026H1全球创新药一级市场共发生505起融资事件，同比增长6.1%，融资金额达到267.5亿美元，同比增长58.5%。2026H1中国相关交易数量及金额涨势迅猛，总金额达997亿美元。从6月初至今，CXO板块在业绩和订单的支撑下，率先于创新药反弹。","market":"nz","thumbnail":"https://static.szfiu.com/news/20241108/NmNiNTg2NTUyNjE5NjAwNw==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/NmNiNTg2NTUyNjE5NjAwNw==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1986787","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06127","LU0417516738.SGD","LU0140636845.USD","03759","BK1610","LU1242518857.USD","LU0823426308.USD","BK1583","HK0000306685.HKD","LU2125910500.SGD","SG9999002562.SGD","HK0000320264.USD","BK1161","02359","LU1880383366.USD","LU0348766576.USD","LU0856984785.SGD","603127","01873","03347","LU0823426480.USD","BK1589","01548","LU1242518931.SGD","WX","LU0516423174.USD","LU0516422952.EUR","LU3063872942.SGD","BK0216","BK1141","LU0327786744.USD","LU0348767384.USD","LU0359201612.USD","KURE","LU0307460666.USD","LU1046422090.SGD","LU0348735423.USD","LU0516422440.USD","06821","BK1191","02269","LU0588546209.SGD","LU0039217434.USD","LU2039709279.SGD","LU2242644610.SGD","CXO","159938","BK1574","LU0043850808.USD","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653772632","title":"中信建投：2026年国内CRO/CDMO行业的新签订单及业绩会加速增长，带动CXO产业链进入新一轮发展阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2653772632","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653772632?lang=zh_cn&edition=fundamental","pubTime":"2026-07-24 08:20","pubTimestamp":1784852419,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["WX","CXO","BK4139","CDMO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653774203","title":"中信建投：CXO板块Beta稳中向好 个股订单加速兑现","url":"https://stock-news.laohu8.com/highlight/detail?id=2653774203","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653774203?lang=zh_cn&edition=fundamental","pubTime":"2026-07-24 07:45","pubTimestamp":1784850351,"startTime":"0","endTime":"0","summary":"26年至今国内创新药行业的长期结构性机会持续兑现，国内投融资持续改善，新药物形式赛道持续火热并进一步放量，26年国内CRO/CDMO行业的新签订单及业绩会加速增长，带动CXO产业链进入新一轮发展阶段。随着资金由融资端向CXO逐级传导，叠加板块估值仍处历史较低水平，行业业绩与估值有望持续修复。行业调整基本完成，Beta修复与个股Alpha进入兑现期。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1471713.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["601066","WX","CXO","BK0276"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":4,"totalSize":65,"code":"91000000","status":"200"}]}}